US Stock MarketDetailed Quotes

PTCT PTC Therapeutics

Watchlist
  • 51.820
  • +2.150+4.33%
Close Feb 14 16:00 ET
  • 52.000
  • +0.180+0.35%
Pre 06:08 ET
4.00BMarket Cap-8.72P/E (TTM)

About PTC Therapeutics Company

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.

Company Profile

SymbolPTCT
Company NamePTC Therapeutics
Listing DateJun 20, 2013
Issue Price15.00
Founded1998
CEODr. Matthew B. Klein, F.A.C.S.,M.D.,M.S.
MarketNASDAQ
Employees995
Fiscal Year Ends12-31
Address500 Warren Corporate Center Drive
CityWarren
ProvinceNew Jersey
CountryUnited States of America
Zip Code07059
Phone1-908-222-7000

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Matthew B. Klein, F.A.C.S.,M.D.,M.S.
  • Director, President and Chief Executive Officer
  • 8.94M
  • Neil Alead
  • Chief Technical Operations Officer
  • --
  • Dr. Lee Golden, M.D.
  • Executive Vice President and Chief Medical Officer
  • 2.39M
  • Pierre Gravier
  • Chief Financial Officer
  • 2.73M
  • Mark E. Boulding
  • Executive Vice President and Chief Legal Officer
  • 2.19M
  • Eric Pauwels
  • Chief Business Officer
  • 2.41M
  • Christine Utter
  • Senior Vice President, Chief Accounting Officer and Head, People Services
  • --
  • Michael Schmertzler
  • Chairman of the Board
  • 816.96K
  • Dr. Glenn D. Steele, M.D., Ph.D.
  • Independent Director
  • 426.98K
  • Dr. Jerome Bernard Zeldis, M.D.,PhD
  • Independent Director
  • 421.98K
  • Dr. Allan Jacobson, PhD
  • Independent Director
  • 511.98K
  • Stephanie S. Okey, M.S.
  • Independent Director
  • 421.98K
  • Mary Smith
  • Independent Director
  • 438.98K
  • William F. Bell, Jr
  • Independent Director
  • 688.36K
  • David P. Southwell
  • Independent Director
  • 438.98K
  • Emma Reeve
  • Independent Director
  • 441.98K
  • Alethia Young
  • Independent Director
  • 428.98K

Trending Stocks

Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.